These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 6690843)
1. The effects of syngeneic soluble tumor membrane extract on concomitant spleen cell immunity and spontaneous metastases. Temple WJ; Sugarbaker EV; Ketcham AS J Surg Res; 1984 Jan; 36(1):71-9. PubMed ID: 6690843 [TBL] [Abstract][Full Text] [Related]
2. The specificity of concomitant tumor immunity at large tumor volumes. Deckers PJ; Pardridge DH; Wang BS; Mannick JA Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994 [TBL] [Abstract][Full Text] [Related]
3. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen. Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053 [TBL] [Abstract][Full Text] [Related]
4. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action. Evans R Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893 [TBL] [Abstract][Full Text] [Related]
5. Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens. Morishita H; Shiku H; Horibe K; Obata Y; Stockert E; Oettgen HF; Old LJ; Yamada K J Exp Med; 1986 Feb; 163(2):452-7. PubMed ID: 3003228 [TBL] [Abstract][Full Text] [Related]
7. Differential activation of cytotoxic and suppressor T cells against syngeneic tumors in the mouse. Yamauchi K; Fujimoto S; Tada T J Immunol; 1979 Oct; 123(4):1653-8. PubMed ID: 90095 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver. Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826 [TBL] [Abstract][Full Text] [Related]
9. Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas. Indrová M; Bubeník J Folia Biol (Praha); 1979; 25(2):137-41. PubMed ID: 456694 [TBL] [Abstract][Full Text] [Related]
10. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Srivastava PK; DeLeo AB; Old LJ Proc Natl Acad Sci U S A; 1986 May; 83(10):3407-11. PubMed ID: 3458189 [TBL] [Abstract][Full Text] [Related]
11. Blocking of syngeneic effector T cells by soluble tumour antigens. Plata F; Levy JP Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403 [No Abstract] [Full Text] [Related]
12. Cellular immune reactivity in vitro and tumor rejection provided by tumor-associated antigens of friend-virus-induced leukemia. Dean JH; McCoy JL; Law LW; Maurer BA; Appella E Int J Cancer; 1975 Nov; 16(5):701-12. PubMed ID: 1184239 [TBL] [Abstract][Full Text] [Related]
13. Expansion of tumor-specific cytolytic T lymphocytes using in vitro restimulation with tumor-specific transplantation antigen. Naito K; Pellis NR; Kahan BD Cell Immunol; 1987 Sep; 108(2):483-94. PubMed ID: 3113743 [TBL] [Abstract][Full Text] [Related]
14. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas. Pellis NR; Tom BH; Kahan BD J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043 [No Abstract] [Full Text] [Related]
16. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens. Ng AK; Ames RS; McIntire RK; Herberman RB Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218 [TBL] [Abstract][Full Text] [Related]
17. [Persistance of cytotoxic activity against a syngeneic tumor after removal of the tumor]. Lafontaine N; Firket H C R Acad Hebd Seances Acad Sci D; 1973 Oct; 277(13):1261-3. PubMed ID: 4205925 [No Abstract] [Full Text] [Related]
18. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens. Frbes JT; Nakaw Y; Smith RT J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages. Landolfo S; Herberman RB; Holden HT J Immunol; 1977 Apr; 118(4):1244-8. PubMed ID: 191532 [TBL] [Abstract][Full Text] [Related]
20. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Plata F; Jongeneel V; Cerottini JC; Brunner KT Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]